Spotlight on Batten Disease
On August 13, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Batten disease. They learned about the current clinical trial for Batten disease, the process of bringing stem cell-based therapies to clinical trial, and the impact of Batten disease on families from Tony Ferrandino.
- Welcoming remarks: Robert Klein, J.D., Chair of the Governing Board and Ed Penhoet, Ph.D., member of the Governing Board
- Stephen Huhn, M.D., F.A.C.S., F.A.A.P., Vice President and Head of the Neural Program, StemCells, Inc.
- Ann Tsukamoto, Ph.D., Chief Operating Officer, StemCells, Inc.
- Tony Ferrandino, father of Batten disease patient